Sotera Health Company (NASDAQ:SHC) Receives Consensus Recommendation of "Moderate Buy" from Analysts

Key Points

• Sotera Health Company (NASDAQ:SHC) has received a consensus recommendation of "Moderate Buy" from five research firms, with one hold and four buy ratings.
• The company reported $0.20 earnings per share for the last quarter, exceeding estimates and showing a 6.4% increase in revenue compared to the previous year.
• Insider transactions saw significant shares sold recently, with notable sales totaling over $123 million, indicating changes in ownership stakes among executives.

Sotera Health Company (NASDAQ:SHC - Get Free Report) has earned a consensus recommendation of "Moderate Buy" from the five research firms that are presently covering the company, Marketbeat.com reports. One analyst has rated the stock with a hold recommendation and four have assigned a buy recommendation to the company. The average 1 year price objective among brokers that have updated their coverage on the stock in the last year is $16.00.

SHC has been the subject of several research reports. Wall Street Zen upgraded shares of Sotera Health from a "buy" rating to a "strong-buy" rating in a research note on Saturday, August 16th. Barclays reiterated an "overweight" rating on shares of Sotera Health in a research note on Friday, August 8th.

Sotera Health Price Performance

Shares of SHC opened at $16.05 on Monday. The company has a market cap of $4.56 billion, a price-to-earnings ratio of 200.65 and a beta of 1.83. Sotera Health has a twelve month low of $9.53 and a twelve month high of $16.99. The company has a quick ratio of 2.23, a current ratio of 2.47 and a debt-to-equity ratio of 4.49. The company has a 50 day moving average of $13.78 and a two-hundred day moving average of $12.42.

Sotera Health (NASDAQ:SHC - Get Free Report) last announced its earnings results on Friday, August 8th. The company reported $0.20 earnings per share for the quarter, beating the consensus estimate of $0.17 by $0.03. The company had revenue of $294.34 million during the quarter, compared to the consensus estimate of $275.81 million. Sotera Health had a net margin of 2.14% and a return on equity of 39.42%. Sotera Health's revenue was up 6.4% compared to the same quarter last year. During the same period last year, the firm earned $0.19 earnings per share. Sotera Health has set its FY 2025 guidance at 0.750-0.820 EPS. As a group, analysts predict that Sotera Health will post 0.61 earnings per share for the current fiscal year.

Insider Transactions at Sotera Health

In other news, insider Michael P. Rutz sold 126,611 shares of Sotera Health stock in a transaction on Friday, August 22nd. The shares were sold at an average price of $16.38, for a total transaction of $2,073,888.18. Following the completion of the sale, the insider directly owned 450,204 shares in the company, valued at approximately $7,374,341.52. The trade was a 21.95% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, Director Gtcr Investment Xi Llc sold 8,000,000 shares of the business's stock in a transaction on Friday, September 5th. The shares were sold at an average price of $15.11, for a total transaction of $120,880,000.00. Following the transaction, the director owned 41,215,301 shares of the company's stock, valued at $622,763,198.11. This represents a 16.26% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 20,126,611 shares of company stock worth $304,273,888. Company insiders own 55.12% of the company's stock.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently added to or reduced their stakes in the business. State of Wyoming lifted its position in Sotera Health by 420.6% during the second quarter. State of Wyoming now owns 66,092 shares of the company's stock valued at $735,000 after purchasing an additional 53,397 shares during the period. Vident Advisory LLC lifted its position in Sotera Health by 23.9% during the second quarter. Vident Advisory LLC now owns 17,419 shares of the company's stock valued at $194,000 after purchasing an additional 3,364 shares during the period. Tidal Investments LLC acquired a new position in Sotera Health during the second quarter valued at $199,000. Sculptor Capital LP lifted its position in Sotera Health by 27.2% during the second quarter. Sculptor Capital LP now owns 11,500,000 shares of the company's stock valued at $127,880,000 after purchasing an additional 2,462,489 shares during the period. Finally, Onex Canada Asset Management Inc. lifted its position in Sotera Health by 61.6% during the second quarter. Onex Canada Asset Management Inc. now owns 414,095 shares of the company's stock valued at $4,605,000 after purchasing an additional 157,826 shares during the period. 91.03% of the stock is currently owned by institutional investors and hedge funds.

Sotera Health Company Profile

Sotera Health Company engages in the provision of sterilization, lab testing, and advisory services in the United States and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. It provides mission-critical end-to-end sterilization services, including gamma and electron beam irradiation, and ethylene oxide processing, as well as designs, installs, and maintains gamma irradiation systems.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.